SETHAWUD CHAIKITGOSIYAKUL

Developed ISO 15189-ready Quality Management System (QMS) packs and 200+ standardized documents, significantly boosting compliance and audit readiness.

Advised 5+ medical labs on setup, workflow design, and vendor coordination, developing comprehensive business plans and financial models to guide investment.

Designed and implemented standardized molecular testing workflows across infectious diseases and genetic testing, ensuring robust acceptance criteria and result validation.

Supported Chulalongkorn University research by enhancing lab techniques and data handling, resulting in curated datasets and publication-ready scientific summaries.

Directed strategic business planning and financial modeling, ensuring long-term sustainability through feasibility studies and market analysis.

Designed and implemented an advanced laboratory service portfolio, integrating Real-time PCR, dPCR, NGS, WGS, and Direct-to-Consumer (DTC) genetic testing to capture diverse market segments.

Forged high-value B2B partnerships with private hospitals and clinics, expanding market penetration and optimizing referral networks for precision medicine services.

Forecasted $254M in revenue by Year 5 with a 992% ROI, validating commercial viability for the new venture.

Developed a 5-year business plan and investor-ready model, achieving a $6.27M valuation with projected $144M Year 5 revenue and 480% ROI.

Drove market entry through SWOT analysis and a B2B go-to-market strategy, targeting 75% hospital networks and 18% private clinics.

Defined the operating model for high-complexity genetics (NGS, dPCR, advanced clinical testing) and curated a portfolio including PGx (31 genes/298 drugs), 72-gene lung panel, and BRCA1/2.

Engineered a cost-effective, high-throughput, regulation-ready service model, improving access and affordability of genetic testing.

Managed end-to-end lifecycle for surgical/diagnostic instruments, enhancing adoption and satisfaction through technical support and sales training.

Expanded general laboratory operations, increasing overall capacity by 65% and growing the test menu from 120 to 185 assays.

Launched and commercialized new molecular diagnostics services, increasing test volume by 35% within the first quarter.

Developed the company's first DTC genetics offering, including at-home collection kits and telemedicine.

Formed premium international genetic-testing referral partnerships with CeGaT (Germany) and Novogenia (Austria), establishing efficient out-lab testing workflows and sample tracking.

Reduced reagent costs by up to 70% for SARS-CoV-2 and HPV DNA through strategic supplier re-negotiation and alternative validation.

Achieved ISO 15189 and ISO 15190 accreditation within one year by authoring 100+ SOPs and implementing a rigorous Quality Management System (QMS).

Established a molecular diagnostics lab with scalable workflows and robust biosafety measures, securing Department of Medical Sciences certifications for HPV DNA and SARS-CoV-2 testing.

Implemented LIMS, reducing report generation time by 98% (from 86 to 1.3 mins) and data entry errors by 83%.

Managed P&L and daily operations for 10,000+ tests/year, supervising a 20+ member laboratory team and ensuring quality workflows.

Led greenfield establishment of the RSAT Nakhon Sawan Medical Technology Clinic, overseeing facility design, procurement, recruitment, and licensing.

Directed laboratory quality initiatives, including preparing for Laboratory Accreditation and implementing foundational QMS elements.

Managed high-volume HIV/STI testing for 12,000+ clients/year, ensuring regulatory compliance and high diagnostic accuracy.

Performed high-volume clinical laboratory tests and phlebotomy with strict QA/QC, ensuring prompt and precise diagnostic results for patient care and clinical decisions.

Developed quality documents for HIV/STI diagnostics and trained staff to ensure accuracy and confidentiality.

Founded and administered 'HIV on Click,' an online platform providing HIV/AIDS education and telemedicine counseling to 3,000+ individuals.

Performed malaria diagnostics for over 1,500 cases, contributing to reduced local prevalence through prevention education.